The need
Client support should not stop when the appointment ends.
← Ventures & experience
In development
Continuum
Turning the work between appointments into a product.
OLSEN STEINER ROLE · VENTURE DEVELOPMENT · OPERATING SUPPORTVisit → Care plan → Approval
PilotPreparation stage
10–20Target pilot therapists
B2B SaaSRecurring model
No appClient access principle
Current venture / development case. Financial projections and valuation scenarios, where shown, are illustrative — not forecasts, appraisals or financing offers.
THE CASE IN ONE VIEW
The need. The model.
The role we play.
The model
Care plans, follow-ups and practitioner-approved recommendations.
Our role
Venture development and operating-workflow design.
HOW THE MODEL CONNECTS
From one step
to the next.
01Visit→
02Plan→
03Approve→
04Follow up→
05Return
FULL CONTEXT
The complete background, on demand.
The visual overview is the short route. Open a chapter to read the original explanation and supporting detail.
Continuum
VENTURE INVESTMENT CASE
CURRENT VENTURE · CARE TECHNOLOGY
OLSEN STEINER ROLE · VENTURE DEVELOPMENT · OPERATING SUPPORTContinuum
Turning the work between appointments into a product.
PilotPreparation stage
10–20Target pilot therapists
B2B SaaSRecurring model
No appClient access principle
OUR METHODOLOGY
Reference frameworks for this project
These are selected development priorities, not claims that every method has already been implemented or validated.
Jobs to Be Done
Understand the progress people need.
Start from the situation and desired progress, not a feature list.
Clayton Christensen and collaborators · Jobs to Be Done
Our application & source
MVP priority: support the work between visits for both the practitioner and the client, instead of adding another administrative inbox.
Motivation · Ability · Prompt
Make the next useful action easier.
Behavior depends on motivation, ability and a prompt coming together.
BJ Fogg · Fogg Behavior Model
Our application & source
MVP priority: one clear practitioner-approved action and an easy check-in at an appropriate time; reminders remain optional and proportionate.
Plan → Do → Study → Act
Learn before scaling.
A disciplined cycle of small tests, observation and revision.
W. Edwards Deming / Walter Shewhart · PDSA
Our application & source
Pilot discipline: study completion, practitioner workload and client feedback before expanding the workflow. These are product tests, not claims of clinical effectiveness.
Original illustrations and paraphrased summaries by Olsen Steiner. References do not imply author endorsement, partnership, a licence to reproduce proprietary materials or certification.
FUNDING DEVELOPMENT LENS
Match the eligible work. Not just the project label.
Assess genuine innovation, research collaboration or workforce-development components where a call matches the applicant and proposed work. Do not imply medical validation or grant eligibility from the product category alone.
What we would assess
Applicant entity and jurisdiction; programme purpose; eligible work and costs; partners; timetable; co-funding and cash flow; procurement or state-aid requirements where applicable; and delivery evidence. This is an assessment pathway, not a claim of an award, submitted application, eligibility or a secured municipal partnership.
Discuss a funding routeCASE EXPLORER
The detail, when you need it.
Open a chapter for the operating evidence, economics, partners or development assumptions. All financial qualifications and source links remain with their context.
INVESTMENT / OPERATING THESISThe gap is not the appointment. It is everything between appointments.+
INVESTMENT / OPERATING THESIS
The gap is not the appointment. It is everything between appointments.
Continuum is designed around continuity of care: structured plans, follow-ups, check-ins and practitioner-controlled communication rather than another scheduling tool.
Workflow fit comes first
The product has to save practitioners time before AI features matter.
Professional control is non-negotiable
AI prepares and assists; practitioners retain approval of client-facing recommendations.
Recurring value must be visible
A subscription product needs repeated workflow utility, not novelty usage.
MARKET FOOTPRINTBuilt from a cross-market operating context.+
MARKET FOOTPRINT
Built from a cross-market operating context.
The product thesis is informed by specialist-service operations in Vietnam and Portugal while the pilot is being prepared for a broader professional market.
PortugalEuropean operating context
VietnamService-business operating context
English baselineInitial product language
Studio segmentPrimary B2B buyer
Bars represent current product-development relevance, not addressable-market size.
BUSINESS MODELA care cycle rather than a single transaction.+
BUSINESS MODEL
A care cycle rather than a single transaction.
The product is structured around the practitioner-client relationship over time.
01Visit
Practitioner captures context.
02Plan
Structured recommendations are prepared.
03Approve
Professional reviews client-facing output.
04Follow up
Check-ins and actions continue between visits.
05Return
Context carries into the next appointment.
COMMERCIAL / FINANCIAL LENSRecurring SaaS economics under pilot validation.+
COMMERCIAL / FINANCIAL LENS
Recurring SaaS economics under pilot validation.
This is a pre-scale venture. The important financial question is whether workflow value converts into durable paid retention.
Revenue modelRecurring subscription
B2B SaaS for solo practitioners and studios.
Primary buyerStudio owner / practitioner
The economic buyer is close to day-to-day workflow pain.
Capital intensityLow physical / high product
Software development and iteration dominate early investment.
Key proofRetention
Activation matters, but recurring use and renewal will determine quality of revenue.
2 / 3 / 5 YEAR VENTURE PATHFrom pilot workflow to category infrastructure.+
2 / 3 / 5 YEAR VENTURE PATH
From pilot workflow to category infrastructure.
Strategic scenario only. The purpose is to show what the venture is trying to become if pilot retention and paid conversion validate the model.
Prove paid retention
Move from pilot validation to a repeatable solo / studio acquisition motion.
- 50–100 paying accounts as an illustrative adoption band
- Activation and weekly-use discipline established
- Practitioner-approved AI workflow hardened
- Portugal / English-speaking pilot markets prioritised
Build studio operating infrastructure
Expand from care plans into a deeper practitioner / studio workflow layer.
- 250–500 paying accounts as an illustrative band
- Multi-practitioner studio administration
- Messaging / booking / client-context integrations
- Partner-led distribution through specialist networks
Become the continuity layer
A cross-market B2B platform for specialist care businesses where client context persists between appointments.
- 1,500–3,000 paying accounts as an illustrative band
- APIs and ecosystem integrations
- Benchmarking / protocol intelligence
- Multi-country product and partner distribution
Pricing basis€49–€149+Current Solo / Studio architecture before add-on therapists.
Year 2€60k–€180k ARRIllustrative, using roughly €100–€150 blended monthly account value.
Year 3€300k–€900k ARRIllustrative adoption range; not a forecast.
Year 5€1.8m–€5.4m ARRScenario range if multi-market retention is proven.
Scenario ranges are strategic planning tools, not management guidance or investment promises.
ILLUSTRATIVE VALUATION FRAMEThe valuation case begins only after retention becomes measurable.+
ILLUSTRATIVE VALUATION FRAME
The valuation case begins only after retention becomes measurable.
Continuum is still pre-scale. The ranges below are scenario mathematics, not a present valuation. They apply a broad 3–8× B2B SaaS revenue reference band to the 2 / 3 / 5-year ARR scenarios already shown on this page.
YEAR 2 · PAID RETENTION€0.2m–€1.4m
Illustrative EV range using €60k–€180k ARR. The key proof is whether practitioners keep using and paying after novelty disappears.
VALUATION DRIVER · ACTIVATION + RETENTION + LOW SUPPORT BURDENYEAR 3 · STUDIO PLATFORM€0.9m–€7.2m
Illustrative range using €300k–€900k ARR if studio accounts, practitioner seats and workflow integrations expand predictably.
VALUATION DRIVER · NRR + ACV EXPANSION + MULTI-PRACTITIONER USEYEAR 5 · CONTINUITY LAYER€5.4m–€43m
Illustrative range using €1.8m–€5.4m ARR. The upper end requires strong recurring revenue quality, multi-market growth and a defensible data / workflow position.
VALUATION DRIVER · CATEGORY OWNERSHIP + ECOSYSTEM INTEGRATIONWhy a wide range
2026 private SaaS transactions show material dispersion: slower or smaller businesses trade around low-single-digit revenue multiples, while high-quality growth assets can command substantially more. Continuum has not yet earned a premium multiple.
What would justify the premium
High practitioner retention, healthy gross margin, expanding studio ACV, low implementation friction, secure client-context infrastructure and clear evidence that the product becomes part of weekly workflow.
WHAT MADE IT HARDExecution risk, not presentation risk.+
WHAT MADE IT HARD
Execution risk, not presentation risk.
These cases are included because they required real operating decisions, not because every element was frictionless.
If data entry creates more work than it saves, adoption fails.
Nice-to-have engagement is insufficient for recurring SaaS economics.
Care-related context requires disciplined permissions and data isolation.
Professional approval and clear boundaries are essential for credibility.
PARTNERSHIP / CAPITAL FITThe best early capital is paired with practitioner distribution.+
PARTNERSHIP / CAPITAL FIT
The best early capital is paired with practitioner distribution.
Continuum benefits most from partners who can help validate retention, bring studio cohorts and accelerate trusted workflow integrations.
01 · PILOTExpand real practitioner cohorts
More studios, more specialties and enough usage to separate true retention from pilot enthusiasm.
02 · PRODUCTHarden privacy and workflow depth
Tenant isolation, permissions, integrations, client context and practitioner-approved AI.
03 · GO-TO-MARKETBuild repeatable studio acquisition
Partnership-led distribution, specialist networks and a disciplined conversion funnel.
Workflow investors
Investors comfortable with practitioner software, trust, privacy and long-term workflow adoption.
Studio / practitioner groups
Distribution partners able to provide credible cohorts and implementation feedback.
Vertical software capital
Capital aligned with recurring B2B SaaS rather than consumer-health speculation.
OLSEN STEINER ROLEVenture development from operating problem to pilot.+
OLSEN STEINER ROLE
Venture development from operating problem to pilot.
Olsen Steiner is shaping the product around an observed operating problem, defining the commercial model, workflow, pilot structure and the boundary between AI assistance and professional responsibility. The venture is intentionally being validated before scale.
STRATEGIC PARTNERSHIP / CAPITALHelp prove that continuity of care can become durable workflow software.+
STRATEGIC PARTNERSHIP / CAPITAL
Help prove that continuity of care can become durable workflow software.
Olsen Steiner is open to selected conversations with pilot networks, studio groups, care-technology partners and strategic investors aligned with practitioner-led adoption.
THE NEXT CONVERSATION
A defined challenge.
A practical way forward.
Tell us the market, the opportunity and what needs to happen next.